Abnormalities of Sphingolipids Metabolic Pathways in the Pathogenesis of Psoriasis
Metabolites · 16.02.2023 · 13 (2) · 291
DOI: 10.3390/metabo13020291 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 16.02.2023. Verfasst von Beatriz Burger und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Nutrientes e Reparo Tecidual, Faculdade de Ciências Aplicadas, Universidade Estadual de Campinas, Limeira 13484-350, SP, Brazil. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, Coordenação de Aperfeicoamento de Pessoal de Nível Superior, National Council for Scientific and Technological Development.
Abstract (Originalsprache)
Psoriasis is immune-mediated skin disorder affecting thousands of people. Sphingolipids (SLs) are bioactive molecules present in the epidermis, involved in the following cellular processes: proliferation, differentiation, and apoptosis of keratinocytes. Alterations in SLs synthesis have been observed in psoriatic skin. To investigate if the imbalance in lipid skin metabolism could be related to psoriasis, we analyzed the gene expression in non-lesioned and lesioned skin of patients with psoriasis available in two datasets (GSE161683 and GSE136757) obtained from National Center for Biotechnology Information (NCBI). The differentially expressed genes (DEGs) were searched for using NCBI analysis, and Gene Ontology (GO) biological process analyses were performed using the Database of Annotation, Visualization, and Integrated Discovery (DAVID) platform. Venn diagrams were done with InteractiVenn tool and heatmaps were constructed using Morpheus software. We observed that the gene expression of cytoplasmic phospholipase A2 (PLA2G4D), glycerophosphodiester phosphodiesterase domain containing 3 (GDP3), arachidonate 12-lipoxygenase R type (ALOX12B), phospholipase B-like 1 (PLBD1), sphingomyelin phosphodiesterase 3 (SMPD3), ganglioside GM2 activator (GM2A), and serine palmitoyltransferase long chain subunit 2 (SPTLC2) was up-regulated in lesioned skin psoriasis when compared with the non-lesioned skin. These genes are related to lipid metabolism and more specifically to sphingolipids. So, in the present study, the role of sphingolipids in psoriasis pathogenesis is summarized. These genes could be used as prognostic biomarkers of psoriasis and could be targets for the treatment of patients who suffer from the disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratório de Nutrientes e Reparo Tecidual, Faculdade de Ciências Aplicadas, Universidade Estadual de Campinas, Limeira 13484-350, SP, Brazil.
ORCID-Profile: Beatriz Burger
Förderung
- São Paulo Research Foundation
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- National Council for Scientific and Technological Development
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Burger, B., Sagiorato, R. N., Cavenaghi, I., & Rodrigues, H. G. (2023). Abnormalities of Sphingolipids Metabolic Pathways in the Pathogenesis of Psoriasis. Metabolites, 13(2), 291. https://doi.org/10.3390/metabo13020291
Vancouver
Burger B, Sagiorato RN, Cavenaghi I, Rodrigues HG. Abnormalities of Sphingolipids Metabolic Pathways in the Pathogenesis of Psoriasis. Metabolites. 2023;13(2):291. doi:10.3390/metabo13020291
BibTeX
@article{Burger2023,
author = {Burger, Beatriz and Sagiorato, Roberta Nicolli and Cavenaghi, Isabella and Rodrigues, Hosana Gomes},
title = {Abnormalities of Sphingolipids Metabolic Pathways in the Pathogenesis of Psoriasis},
journal = {Metabolites},
year = {2023},
volume = {13},
number = {2},
pages = {291},
doi = {10.3390/metabo13020291}
}
EUVIMED